# US Global Prescribed Health apps Market > US Prescribed Health Apps Market Research Report By Type (Windows, iPhones, Androids, others), By Devices (Cardiac monitoring device, Diabetes management device, Multi-parameter tracker, Others) and By Application (Individual, Hospitals) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.87% - **2024:** $ 118.14 Million - **2025:** $ 126.26 Million - **2035:** $ 245.41 Million - **Key Players:** Apple Inc (US), Samsung Electronics (KR), Cerner Corporation (US), Allscripts Healthcare Solutions (US), Epic Systems Corporation (US), Medtronic (US), Philips Healthcare (NL), IBM Watson Health (US), Omada Health (US) **Report ID:** MRFR/HCIT/18473-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-global-prescribed-health-apps-market-20020 --- ## Market Summary ## **US Prescribed Health Apps Market Overview** As per MRFR analysis, the US Prescribed Health Apps Market Size was estimated at 4.46 (USD Million) in 2023.The US Prescribed Health Apps Market Industry is expected to grow from 6.25(USD Million) in 2024 to 30.85 (USD Million) by 2035. The US Prescribed Health Apps Market CAGR (growth rate) is expected to be around 15.618% during the forecast period (2025 - 2035). ### **Key US Prescribed Health Apps Market Trends Highlighted** The US Prescribed Health Apps Market is experiencing notable trends driven by increasing adoption of digital health solutions among both patients and healthcare providers. One of the key market drivers is the growing focus on personalized healthcare, where mobile health applications allow for tailored treatment plans through real-time data and patient monitoring. The convenience and accessibility of these apps make them an essential component of managing chronic diseases, which aligns with public health initiatives aimed at reducing healthcare costs and improving patient outcomes. Opportunities to be explored in this market include the potential for integration with wearable technology and remote patient monitoring devices, which can enhance data collection and engagement. As telehealth continues to gain traction, especially following the COVID-19 pandemic, health apps that complement virtual consultations are likely to see increased usage, opening up avenues for innovation. Additionally, regulatory support for mobile health apps, backed by government efforts to promote digital health solutions, presents a fertile ground for new entrants aiming to develop specialized applications. Recent trends also reflect the rise of mental health apps, driven by a growing awareness of mental wellness and the need for accessible mental health resources in the US. As federal legislation increasingly supports mental health initiatives, consumption of related applications is expected to increase. Moreover, user-centered design and patient engagement features have gained importance, as apps strive to offer seamless experiences that cater to varying user demographics and needs. Increased collaboration between developers, healthcare professionals, and regulatory entities further signifies that the market is evolving to meet the specific demands of healthcare delivery in the US. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Prescribed Health Apps Market Drivers** ### **Growing Adoption of Digital Health Solutions** The increasing shift towards digital health solutions in the United States is a significant driver for the US Prescribed Health Apps Market Industry. According to the Office of the National Coordinator for Health Information Technology, nearly 86% of hospitals in the US had adopted at least one type of digital health technology by 2022. This adoption is largely influenced by successful initiatives from organizations like the American Medical Association (AMA) and the National Institutes of Health (NIH), which have promoted the integration of technology into healthcare to enhance patient outcomes. The U.S. government has also been actively supporting telehealth regulations, which allows the seamless inclusion of prescribed health apps into standard care practices, resulting in greater acceptance among healthcare providers and patients alike. This growing dependence on digital solutions is anticipated to fuel significant market growth in the upcoming years. ### **Rising Incidence of Chronic Diseases** The surge in chronic diseases such as diabetes, hypertension, and obesity in the United States is a crucial driver for the US [Prescribed Health Apps Market](../../../reports/global-prescribed-health-apps-market-758) Industry. The Centers for Disease Control and Prevention (CDC) report that about 6 in 10 adults in the U.S. live with at least one chronic condition, and this figure has been steadily rising. Organizations like the American Heart Association and the Diabetes Association emphasize the need for continuous monitoring and management of these diseases, leading to an increase in the use of health apps that allow for timely intervention and data tracking. As healthcare systems adapt to accommodate these apps, the demand for prescribed health apps is expected to grow rapidly, aligning with expectations for an increase in chronic health management technologies. ### **Government Support and Policy Enhancements** Increased governmental support for health technology innovations positively influences the US Prescribed Health Apps Market Industry. The U.S. government has rolled out various initiatives, such as the Health Information Technology for Economic and Clinical Health (HITECH) Act, that incentivize healthcare providers to adopt technology solutions, including prescribed health applications. By 2020, the federal government's reimbursement strategies for telehealth have expanded significantly, promoting the utilization of these apps within standard patient care practices. This has been supported by the Centers for Medicare & Medicaid Services (CMS), which introduced new billing codes related to telehealth services, encouraging the financial adoption of prescribed health apps by medical practices. Such governmental backing of digital health solutions positions the prescribed health apps market for robust growth. ### **Increasing Health Awareness among Consumers** The growing awareness about health and wellness among consumers in the United States is another pivotal driver for the US Prescribed Health Apps Market Industry. According to a survey conducted by Pew Research Center, over 80% of Americans believe their health is helped by digital health apps, indicating a cultural shift towards proactive health management. This increased health consciousness is being mirrored by significant efforts from organizations like the American Public Health Association, which advocates for health education and awareness, resulting in more consumers opting for prescribed health apps for personal health monitoring and management. Consequently, as the population becomes progressively health-savvy and desires immediate access to healthcare, the demand for prescribed health apps is expected to see significant enhancement. ## **US Prescribed Health Apps Market Segment Insights** ### **Prescribed Health Apps Market Type Insights** The US Prescribed Health Apps Market market under the Type segment showcases a diverse range of applications tailored to various operating systems such as Windows, iPhones, Androids, and others. As the demand for digital health solutions grows, particularly in the US, these apps play a crucial role in enhancing patient care and promoting healthier lifestyles. Windows-based applications have found a niche among health professionals and institutions due to their robust features and reliability for fulfilling complex health tracking needs. iPhones, with their user-friendly interface and extensive integrations, dominate the consumer market, allowing patients easy access to health management tools directly from their smartphones. Android apps are significant as they cater to a vast demographic of users, capitalizing on the affordability and accessibility of Android devices, which is key in reaching diverse populations across the country. Furthermore, the others category encapsulates unique and innovative platforms that cater to specialized sectors within the healthcare system. Collectively, these types of apps not only improve patient engagement but also facilitate remote health monitoring, ultimately reducing the need for in-person consultations. The market trends indicate that as healthcare continues to embrace technology, users are increasingly looking for personalized health solutions tailored to their specific needs and preferences. Growth drivers such as an aging population, rising chronic diseases, and an increased emphasis on preventive care further amplify the significance of the US Prescribed Health Apps Market. However, challenges such as privacy concerns and varying regulatory standards can impede healthy growth. Despite these obstacles, the expanding acceptance of digital health among both practitioners and patients presents ample opportunities for growth, innovation, and collaboration in the holistic management of health and wellness in the US. The emphasis on seamless data integration and user-friendly formats is transforming the industry, ensuring that the aforementioned types of prescribed health apps continue to grow in significance. Overall, the interplay of technology and healthcare in the US indicates a robust future for the Prescribed Health Apps Market, with various operating systems vying for dominance in capturing the evolving consumer market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Prescribed Health Apps Market Devices Insights** The Devices segment within the US Prescribed Health Apps Market showcases a robust framework aimed at enhancing patient care through innovative technological solutions. This segment encompasses various categories, notably Cardiac monitoring devices, Diabetes management devices, Multi-parameter trackers, and others, each contributing uniquely to health management. Cardiac monitoring devices are particularly significant as they enable real-time tracking of heart rhythms, thus playing a vital role in preventing cardiovascular diseases, which remain a leading health concern in the US. Diabetes management devices support patients in monitoring glucose levels and managing their condition effectively, reflecting the rising prevalence of diabetes across the nation. Multi-parameter trackers merger various health metrics into one device, providing a holistic view of a patient's health status, which is crucial for tailored treatment plans. The increasing adoption of these technologies is driven by a growing awareness of personal health management, supportive reimbursement policies, and advancements in technology. The US government promotes digital health tools to improve health outcomes, indicating substantial investment and familial trust in these devices, presenting opportunities for innovation and enhanced market growth. ### **Prescribed Health Apps Market Application Insights** The Application segment of the US Prescribed Health Apps Market is experiencing notable growth, driven by increasing adoption of technology in healthcare. As healthcare continues to evolve, both individuals and hospitals are leveraging mobile applications to enhance patient outcomes and optimize care delivery. Individual consumers are increasingly turning to health apps to manage personal health, track chronic conditions, and improve wellness, while hospitals utilize these applications to streamline operations, monitor patient health, and provide telehealth services. It is noteworthy that hospitals represent a significant part of the market, as they focus on integrating health applications into their existing systems to enhance operational efficiency and patient engagement. The rise in chronic diseases and the need for accessible health management tools are among the key factors fueling this market growth. Furthermore, with an emphasis on preventive care and patient empowerment, the US Prescribed Health Apps Market segmentation indicates a promising trajectory for both individuals and hospitals. Market growth is further supported by government initiatives promoting digital health solutions, facilitating a favorable environment for innovation and adoption of health apps in the United States. ## **US Prescribed Health Apps Market Key Players and Competitive Insights** The US Prescribed Health Apps Market has demonstrated significant growth as digital health solutions become increasingly integrated into healthcare systems. This market encompasses applications that require a healthcare provider's prescription and are designed to assist patients in managing their medical conditions through technology. Competitive insights in this market are shaped by innovation, regulatory developments, and consumer demand for personalized healthcare solutions. Players in this segment showcase a range of functionalities, from disease management to remote monitoring, which in turn influences their strategies for gaining market share and enhancing user engagement. As healthcare providers and patients alike embrace technology, the competition is becoming fierce, with each company vying to secure its place by delivering effective and user-friendly solutions. WellDoc has carved out a robust position in the US Prescribed Health Apps Market, primarily focusing on type 2 diabetes management through its flagship product that leverages evidence-based algorithms to provide personalized guidance. Its strengths lie in its unique ability to allow integration with electronic health records, fostering collaboration between patients and healthcare providers. This capability ensures that healthcare professionals can monitor their patients' progress in real time and make informed decisions based on accurate data. WellDoc's emphasis on clinical validation and adherence to regulatory requirements further bolster its credibility within the healthcare community. By continuously advancing its technology and maintaining a strong commitment to effectiveness, WellDoc sets itself apart from competitors in a rapidly evolving landscape. Hims and Hers Health has established a notable presence in the US Prescribed Health Apps Market by offering a range of telehealth services and products, primarily focused on sexual health, hair loss, and mental health. The brand's strong emphasis on accessibility has made it a preferred choice for many consumers seeking discreet and convenient healthcare solutions. Hims and Hers Health stands out with its seamless integration of virtual consultations and product fulfillment, making it easy for users to receive prescribed treatments from qualified professionals without the need for in-person visits. The company's strategic partnerships and collaborations, aimed at enhancing its product offerings and expanding reach, have been pivotal for growth. Moreover, recent mergers and acquisitions have allowed Hims and Hers Health to diversify its portfolio, positioning itself strongly in the market. Its focus on user education and support further enhances its appeal, cementing its reputation in the competitive landscape of prescribed health apps in the US. ### **Key Companies in the US Prescribed Health Apps Market Include** ## **US Prescribed Health Apps Market Industry Developments** In recent months, the US Prescribed Health Apps Market has witnessed significant growth and activity.WellDoc has actively expanded its offerings, focusing on chronic disease management through digital platforms, while Hims and Hers Health continues to innovate in telehealth, particularly in mental health services. Epic Systems and Teladoc Health have been improving their digital health services, aiming to enhance patient experience. In October 2023, UnitedHealth Group announced an acquisition of a health tech startup, further solidifying its position in the market. Johnson and Johnson's digital ventures are also on the rise, notably enhancing their health app capabilities for better patient monitoring. Zebra Medical Vision made strides in imaging analytics, which impacts clinical decision-making. Furthermore, Medtronic has been focusing on chronic disease management through advanced apps, while Apple and Samsung are continually integrating health functionalities into their devices. Notably, the market has seen increased investments aimed at improving healthcare access and management, responding to the growing demand for telehealth solutions following the pandemic. Over the past few years, significant advancements have been made in regulatory approval pathways, further facilitating innovation in prescribed health applications. ## **US Prescribed Health Apps Market Segmentation Insights** ### **Prescribed Health Apps Market Type Outlook** ### **Prescribed Health Apps Market Devices Outlook** ### **Prescribed Health Apps Market Application Outlook** ## Market Drivers ### Increased Focus on Preventive Healthcare the prescribed-health-apps market is witnessing a growing emphasis on preventive healthcare, which is reshaping the landscape of health management. With healthcare costs in the US escalating, there is a pressing need to shift from reactive to proactive health strategies. Prescribed health apps play a crucial role in this transition by enabling users to monitor their health indicators and receive timely interventions. Data suggests that preventive measures can reduce healthcare expenditures by up to 30%, making these applications an attractive option for both patients and providers. By promoting healthier lifestyles and early detection of potential health issues, these apps contribute to improved health outcomes and reduced healthcare costs. Consequently, the focus on preventive healthcare is likely to propel the growth of the global prescribed-health-apps market in the coming years. ### Regulatory Changes Favoring Digital Health The global prescribed-health-apps market is experiencing a shift due to regulatory changes that favor the adoption of digital health solutions. Recent policy updates in the US have streamlined the approval process for health apps, making it easier for developers to bring their products to market. This regulatory support is crucial, as it encourages innovation and investment in the sector. For example, the FDA has introduced guidelines that facilitate the development of software as a medical device, which directly impacts the global prescribed-health-apps market. As regulations become more favorable, it is anticipated that the number of prescribed health apps will increase, providing patients with a wider array of options for managing their health. This trend may lead to enhanced competition and further advancements in the quality and effectiveness of health applications. ### Technological Advancements in Mobile Health The global prescribed-health-apps market is significantly influenced by rapid technological advancements in mobile health. Innovations such as artificial intelligence, machine learning, and wearable technology are enhancing the functionality and effectiveness of health applications. For instance, AI-driven analytics can provide personalized health insights, while wearables can track vital signs in real-time. The integration of these technologies is expected to increase user engagement and satisfaction, as they offer tailored health solutions. Market data indicates that the mobile health market is projected to reach $200 billion by 2025, underscoring the potential for growth in the global prescribed-health-apps market. As technology continues to evolve, the capabilities of prescribed health apps will likely expand, attracting more users and healthcare providers alike. ### Rising Demand for Remote Healthcare Solutions The global prescribed-health-apps market is experiencing a notable surge in demand for remote healthcare solutions. This trend is largely driven by the increasing prevalence of chronic diseases in the US, which necessitates continuous monitoring and management. According to recent data, approximately 60% of adults in the US live with at least one chronic condition, creating a substantial need for effective health management tools. Prescribed health apps offer patients the ability to track their health metrics, communicate with healthcare providers, and receive personalized care plans. This shift towards remote healthcare not only enhances patient engagement but also reduces the burden on healthcare facilities, thereby driving growth in the global prescribed-health-apps market. As more patients seek convenient and accessible healthcare options, the demand for these applications is expected to rise significantly. ### Growing Acceptance of Digital Health Solutions The global prescribed-health-apps market is benefiting from the increasing acceptance of digital health solutions among both patients and healthcare professionals. As the healthcare landscape evolves, there is a growing recognition of the value that technology brings to health management. Surveys indicate that over 70% of healthcare providers in the US are now utilizing some form of digital health technology, which includes prescribed health apps. This acceptance is driven by the desire for improved patient outcomes and streamlined healthcare processes. Furthermore, as patients become more tech-savvy, their willingness to adopt digital health solutions is also rising. This trend is likely to foster a more favorable environment for the global prescribed-health-apps market, as both patients and providers seek innovative ways to enhance health management. ## Future Outlook The prescribed-health-apps market is projected to grow at a 6.87% CAGR from 2025 to 2035, driven by technological advancements, increasing health awareness, and regulatory support. **New opportunities:** - Integration of AI-driven analytics for personalized health insights. - Development of subscription-based models for continuous patient engagement. - Partnerships with healthcare providers for integrated care solutions. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare dynamics. ## Segment Insights ### By Type: iPhones (Largest) vs. Androids (Fastest-Growing) In the US global prescribed-health-apps market, iPhones dominate the type segment with a significant market share, showcasing their strong user base and brand loyalty. Meanwhile, Androids are gaining traction, appealing to a broader audience due to their diverse range of devices and price options, thus capturing a noteworthy portion of the market share. The competitive landscape highlights that, while iPhones maintain their supremacy, Androids are rapidly evolving and expanding their customer reach. The growth trends within this segment are driven by increasing smartphone adoption rates and the surge in health-conscious consumers actively seeking health solutions through apps. Moreover, the enhancement of app functionalities, personalization options, and integration with wearable technologies have bolstered the appeal of Androids, which are expected to show rapid growth in user adoption in the coming years. iPhones, however, continue to lead in quality-related user retention, ensuring their position in the market remains stable despite competitive pressures. iPhones (Dominant) vs. Androids (Emerging) The iPhones segment is characterized by its robust ecosystem, offering a seamless user experience which fosters customer loyalty and retention. The premium quality of apps available on this platform attracts health-conscious consumers who value reliability and security in their healthcare management tools. On the other hand, the Androids segment represents an emerging market with diverse offerings catering to different demographics and preferences. The flexibility of the Android platform allows for innovative and cost-effective solutions, appealing to a wide audience. As health applications continue to evolve, both segments are poised for unique growth trajectories, but iPhones maintain a dominant presence owing to their established reputation and high-quality app offerings. ### By Device: Cardiac Monitoring Device (Largest) vs. Multi-parameter Tracker (Fastest-Growing) In the US global prescribed-health-apps market, the cardiac monitoring device segment holds the largest share, driven by an increasing prevalence of cardiovascular diseases and a growing aging population. The diabetes management device and multi-parameter tracker segments are also significant contributors, each catering to specific health monitoring needs, but they lag behind cardiac monitoring in terms of market dominance. Growth trends in this segment indicate a rising demand for advanced health tracking technologies, particularly among chronic disease patients. The integration of AI and remote monitoring features is capturing consumer interest, leading to a surge in adoption rates for multi-parameter trackers, which are quickly emerging as a crucial tool for comprehensive health management, thus making them the fastest-growing segment. Cardiac Monitoring Device (Dominant) vs. Multi-parameter Tracker (Emerging) The cardiac monitoring device segment is established as the dominant player in the US global prescribed-health-apps market, primarily due to its critical role in the ongoing management of heart conditions. These devices provide real-time data, empowering users to take immediate actions based on their heart health. Meanwhile, the multi-parameter tracker serves as an emerging competitor by offering versatile health monitoring capabilities that range across various metrics including heart rate, sleep patterns, and activity levels. It is particularly appealing to health-conscious consumers and those seeking preventative care, thus gaining traction in the consumer base and establishing itself as a vital tool in holistic healthcare. ### By Applications: Individual (Largest) vs. Hospitals (Fastest-Growing) In the US global prescribed-health-apps market, the application segment is primarily dominated by the Individual category, which commands a significant market share. This sector thrives due to the increasing personalization of healthcare solutions that enable users to manage their health. Meanwhile, the Hospitals segment is rapidly gaining traction, expanding its share as more healthcare facilities adopt advanced digital solutions to enhance patient care and operational efficiency. The growth trends for these segments reflect a shift towards digital health engagement among individuals as well as a surge in hospitals adopting prescribed-health applications. Factors such as the rise in chronic diseases, the need for improved patient monitoring, and a growing emphasis on telehealth services are driving this growth. Consequently, the Hospitals segment is expected to continue its upward trajectory, becoming a key player in the overall market space. Applications: Individual (Dominant) vs. Hospitals (Emerging) The Individual application segment in the US global prescribed-health-apps market is characterized by its strong user engagement and a wide array of health management tools that cater to personal health needs. These applications provide users with tailored health solutions, such as medication reminders, fitness tracking, and [mental health](https://www.marketresearchfuture.com/reports/mental-health-market-12354) support, resulting in high adoption rates among consumers. In contrast, the Hospitals segment, while still emerging, is witnessing rapid adoption as healthcare institutions recognize the benefits of integrating technology into patient care. Hospitals are increasingly turning to these applications for better data management, patient engagement, and streamlined health service delivery, indicating a promising growth trajectory that could challenge the dominance of Individual applications in the coming years. ## Competitive Benchmarking The global prescribed-health-apps market is currently characterized by a dynamic competitive landscape, driven by rapid technological advancements and an increasing emphasis on patient-centric care. Key players such as Apple Inc (US), Cerner Corporation (US), and Omada Health (US) are strategically positioning themselves through innovation and partnerships. Apple Inc (US) has been focusing on integrating health monitoring features into its devices, enhancing user engagement and data collection capabilities. Cerner Corporation (US) is leveraging its extensive healthcare data analytics to improve patient outcomes, while Omada Health (US) is emphasizing personalized health solutions through digital interventions. Collectively, these strategies are shaping a competitive environment that prioritizes technological integration and patient engagement.In terms of business tactics, companies are increasingly localizing their operations and optimizing supply chains to enhance efficiency and responsiveness. The market appears moderately fragmented, with a mix of established players and emerging startups. This structure allows for diverse offerings, yet the influence of key players remains substantial, as they set benchmarks for innovation and service delivery. In October Apple Inc (US) announced a partnership with a leading health insurance provider to integrate its health app features into their services. This strategic move is likely to enhance user accessibility and broaden the app's reach, potentially increasing user adoption rates. By aligning with insurance providers, Apple Inc (US) appears to be reinforcing its commitment to health management and preventive care, which could lead to improved health outcomes for users. In September Cerner Corporation (US) launched a new AI-driven analytics platform aimed at streamlining patient data management for healthcare providers. This initiative is significant as it not only enhances operational efficiency but also positions Cerner Corporation (US) as a leader in the integration of AI within healthcare applications. The platform's capabilities may facilitate better decision-making processes for healthcare professionals, thereby improving patient care. In August Omada Health (US) expanded its digital health platform to include new [behavioral health](https://www.marketresearchfuture.com/reports/behavioral-health-market-66028) modules, addressing a growing need for mental health support. This expansion is indicative of a broader trend towards holistic health solutions, where companies are recognizing the importance of mental well-being alongside physical health. By diversifying its offerings, Omada Health (US) is likely to attract a wider user base and enhance its competitive edge. As of November the most pressing trends in the global prescribed-health-apps market include the increasing digitalization of healthcare, a focus on sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies seek to enhance their technological capabilities and market reach. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition towards innovation, technological advancements, and supply chain reliability. This transition suggests that companies that prioritize these aspects will likely gain a competitive advantage in the increasingly complex healthcare landscape. ## Recent News & Developments In recent months, the US Prescribed Health Apps Market has witnessed significant growth and activity.WellDoc has actively expanded its offerings, focusing on [chronic disease management](https://www.marketresearchfuture.com/reports/chronic-disease-management-market-981) through digital platforms, while Hims and Hers Health continues to innovate in telehealth, particularly in mental health services. Epic Systems and Teladoc Health have been improving their digital health services, aiming to enhance patient experience. In October 2023, UnitedHealth Group announced an acquisition of a health tech startup, further solidifying its position in the market. Johnson and Johnson's digital ventures are also on the rise, notably enhancing their health app capabilities for better patient monitoring. Zebra Medical Vision made strides in imaging analytics, which impacts clinical decision-making. Furthermore, Medtronic has been focusing on chronic disease management through advanced apps, while Apple and Samsung are continually integrating health functionalities into their devices. Notably, the market has seen increased investments aimed at improving healthcare access and management, responding to the growing demand for telehealth solutions following the pandemic. Over the past few years, significant advancements have been made in regulatory approval pathways, further facilitating innovation in prescribed health applications. ## Report Scope | MARKET SIZE 2024 | 118.14(USD Million) | | --- | --- | | MARKET SIZE 2025 | 126.26(USD Million) | | MARKET SIZE 2035 | 245.41(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.87% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Apple Inc (US), Samsung Electronics (KR), Cerner Corporation (US), Allscripts Healthcare Solutions (US), Epic Systems Corporation (US), Medtronic (US), Philips Healthcare (NL), IBM Watson Health (US), Omada Health (US) | | Segments Covered | Type, Device, Applications | | Key Market Opportunities | Integration of artificial intelligence for personalized patient care in the global prescribed-health-apps market. | | Key Market Dynamics | Rising regulatory scrutiny and technological advancements drive innovation in the global prescribed-health-apps market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US global prescribed-health-apps market in 2024?** A: The market valuation was $118.14 Million in 2024. **Q: What is the projected market valuation for the US global prescribed-health-apps market by 2035?** A: The projected valuation for 2035 is $245.41 Million. **Q: What is the expected CAGR for the US global prescribed-health-apps market during the forecast period 2025 - 2035?** A: The expected CAGR is 6.87% during the forecast period 2025 - 2035. **Q: Which companies are considered key players in the US global prescribed-health-apps market?** A: Key players include Apple Inc, Samsung Electronics, Cerner Corporation, Allscripts Healthcare Solutions, Epic Systems Corporation, Medtronic, Philips Healthcare, IBM Watson Health, and Omada Health. **Q: What are the main segments of the US global prescribed-health-apps market by type?** A: The main segments by type include Windows, iPhones, Androids, and Others. **Q: What were the valuations for iPhones in the US global prescribed-health-apps market in 2024?** A: The valuations for iPhones were between $40.0 Million and $80.0 Million in 2024. **Q: What devices are included in the US global prescribed-health-apps market?** A: Devices include cardiac monitoring devices, diabetes management devices, multi-parameter trackers, and others. **Q: What was the valuation range for diabetes management devices in 2024?** A: The valuation range for diabetes management devices was between $30.0 Million and $60.0 Million in 2024. **Q: What applications are considered in the US global prescribed-health-apps market?** A: Applications include individual users and hospitals. **Q: What was the valuation for individual applications in the US global prescribed-health-apps market in 2024?** A: The valuation for individual applications was between $70.0 Million and $150.0 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-global-prescribed-health-apps-market-20020*